Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial

Advances in Therapy

Volumn 26, Issue 2, 2009, Pages 194-207

  Selam, Jean Louis ^a   Meneghini, Luigi F ^b  

^a Diabetes Research Center   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Basal bolus; Insulin detemir; Insulin titration; Long acting insulin analog; PREDICTIVE 303; Type 2 diabetes

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLULISINE; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ALGORITHM; ARTICLE; BODY WEIGHT; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIABETIC KETOACIDOSIS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFECTION; INFESTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PHASE 4 CLINICAL TRIAL; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS; WEIGHT REDUCTION;

AGED; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; SAFETY; SELF ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

EID: 73449124778     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0007-8     Document Type: Article

References (25)

1. Novo Nordisk Inc. Levemir (insulin detemir [rDNA origin] injection) prescribing information. May 16, 2007. Princeton, NJ; 2005.
2. P.C. Bartley M. Bogoev J. Larsen A. Philotheous 2008 Long-term efficacy and safety of insulin detemir compared to neutral protamine hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial Diabet Med 25 442 429 18387078 10.1111/j.1464-5491.2007.02407.x 1:CAS:528:DC%2BD1cXmsFKgtr4%3D
3. T. Haak A. Tiengo E. Draeger M. Suntum W. Waldhausl 2005 Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes Diabetes Obes Metab 7 56 64 15642076 10.1111/j.1463-1326.2004.00373.x 1:CAS:528:DC%2BD2MXhsFGhtLk%3D
4. T.R. Pieber H.C. Treichel B. Hompesch 2007 Comparison of insulin detemir and insulin glargine in subjects with type 1 diabetes using intensive insulin therapy Diabet Med 24 635 642 17381500 10.1111/j.1464-5491.2007.02113.x 1:CAS:528:DC%2BD2sXot12rsrs%3D (Pubitemid 46808860)
5. K. Raslova M. Bogoev I. Raz G. Leth M.-A. Gall N. Hancu 2004 Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes Diabetes Res Clin Pract 66 193 201 15533587 10.1016/j.diabres.2004.03.003 1:CAS:528:DC%2BD2cXpsVKntLg%3D (Pubitemid 39469347)
6. D.L. Russell-Jones R. Simpson B. Hylleberg E. Draeger J. Bolinder 2004 Effects of QD insulin detemir or neutral protamine hagedorn on blood glucose control in patients with type 1 diabetes mellitus using a basal-bolus regimen Clin Ther 26 724 736 15220016 10.1016/S0149-2918(04)90072-0 1:CAS:528: DC%2BD2cXlsFCisL0%3D (Pubitemid 38736962)
7. O. Klein J. Lynge L. Endahl B. Damholt L. Nosek T. Heise 2007 Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes Diabetes Obes Metab 9 290 299 17391154 10.1111/j.1463-1326.2006.00685.x 1:CAS:528:DC%2BD2sXlvVSlu7c%3D (Pubitemid 46502046)
8. T. Heise L. Nosek B.B. Ronn 2004 Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes Diabetes 53 1614 1620 15161770 10.2337/diabetes.53.6.1614 1:CAS:528:DC%2BD2cXkslCgsLc%3D (Pubitemid 38697678)
9. P. Kurtzhals 2004 Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir Int J Obes 28 suppl.2 S23 S28 10.1038/sj.ijo.0802746 1:CAS:528:DC%2BD2cXmsVKlsbg%3D (Pubitemid 39389603)
10. L.F. Meneghini C. Koenen W. Wend J. Selam 2007 The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes - results from the randomized, controlled predictive 303 Study Diabetes Obes Metab 9 902 913 17924873 10.1111/j.1463-1326.2007.00804.x 1:CAS:528:DC%2BD2sXhtlOlsLjI (Pubitemid 47555212)
11. Guidance for Industry. Diabetes Mellitus: Developing Drugs And Therapeutic Biologics for Treatment and Prevention. Rockville, MD: U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); February 2008. Available at: http://www.fda.gov/Cder/Guidance/7630dft.pdf.
12. P. Aschner J. LaSalle M. McGill 2007 The Global Partnership for Effective Diabetes Management. The team approach to diabetes management: partnering with patients Int J Clin Pract Suppl 157 22 30 17991188 10.1111/j.1742-1241.2007. 01606.x (Pubitemid 350076257)
13. B. Kulzer N. Hermanns H. Reinecker T. Haak 2007 Effects of self-management training in type 2 diabetes: a randomized, prospective trial Diabet Med 24 415 423 17298590 10.1111/j.1464-5491.2007.02089.x 1:STN:280:DC%2BD2s7os1KlsA%3D%3D (Pubitemid 46452397)
14. M. Funnell R. Anderson 2004 Empowerment and self-management of diabetes Clin Diabetes 22 123 127 10.2337/diaclin.22.3.123
15. L.F. Meneghini A. Wick A. Delamater 2004 Two year update on group-based self-management intervention for intensification of insulin therapy Diabetes 53 suppl.2 A72
16. M. Davies F. Storms S. Shutler M. Bianchi-Biscay R. Gomis 2005 ATLANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine Diabetes Care 28 1282 1288 15920040 10.2337/diacare.28.6.1282 1:CAS:528:DC%2BD2MXlsFyht7s%3D (Pubitemid 40756686)
17. K. Hermansen M. Davies T. Derezinski G. Martinez P. Clauson P. Home 2006 A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes Diabetes Care 29 1269 1274 16732007 10.2337/dc05-1365 1:CAS:528:DC%2BD28XmtFKlsr4%3D (Pubitemid 44125921)
18. M.C. Riddle J. Rosenstock J. Gerich 2003 Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 3080 3086 14578243 10.2337/diacare.26.11.3080 1:CAS:528:DC%2BD3sXpsFert70%3D (Pubitemid 37339502)
19. M.K. Rhee W. Slocum D.C. Ziemer 2005 Patient adherence improves glycemic control Diabetes Educ 31 240 250 15797853 10.1177/0145721705274927 (Pubitemid 40529013)
20. C.F. Montanana C.H. Herrero M.R. Fernandez 2008 Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight type 2 diabetes patients - the PREDICTIVE BMI clinical trial Diabet Med 25 916 923 10.1111/j.1464-5491.2008. 02483.x 1:CAS:528:DC%2BD1cXhtFSgu7%2FK
21. S. Sreenan A. Virkamaki K. Zhang J.B. Hansen 2008 The PREDICTIVE study group. Switching from NPH insulin to once-daily insulin detemir in basal-bolus treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study Int J Clin Pract 62 1971 1980 19166444 10.1111/j.1742-1241. 2008.01939.x 1:STN:280:DC%2BD1M%2FpvVSksw%3D%3D
22. J. Chao D.P. Nau J.E. Aikens 2007 Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus Clin Ther 29 177 180 17379058 10.1016/j.clinthera.2007.01.014 (Pubitemid 46414033)
23. P. Home P. Kurtzhals 2006 Insulin determir: from concept to clinical experience Expert Opin Pharmacother 7 325 343 16448327 10.1517/14656566.7.3.325 1:CAS:528:DC%2BD28XpsVaruw%3D%3D (Pubitemid 43263250)
24. J. Rosenstock M. Davies P.D. Home J. Larsen C. Koenen G. Schernthaner 2008 A randomised, 52-week, treatto-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetologia 51 408 416 18204830 10.1007/s00125-007-0911-x 1:CAS:528:DC%2BD1cXhtlyls7c%3D
25. K. Raslova S.C. Tamer P. Clauson D. Karl 2007 Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index Clin Drug Investig 27 279 285 17358100 10.2165/00044011-200727040-00007 1:CAS:528:DC%2BD2sXls1Klsb0%3D (Pubitemid 46440300)